Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Classement en actions
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Prix de l'action
$8.03
Capitalisation boursière
$6.31B
Changement (1 jour)
1.07%
Changement (1 an)
-8.04%
Pays
CN
Échange Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Catégorie
Healthcare
Ratio P/B pour Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Ratio P/B au October 2026 TTM : 4.68
Selon les derniers rapports financiers et le cours de l'action de Shenzhen New Industries Biomedical Engineering Co., Ltd., le ratio cours/valeur comptable actuel (TTM) est 4.68. À la fin de 2024, le ratio P/B était de 6.49.
Historique du ratio P/B pour Shenzhen New Industries Biomedical Engineering Co., Ltd. de 2012 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 4.68 | -3.03% |
| 2025 | 4.83 | -25.54% |
| 2024 | 6.49 | -20.27% |
| 2023 | 8.14 | 32.24% |
| 2022 | 6.16 | 0.04% |
| 2021 | 6.15 | -45.62% |
| 2020 | 11.32 | 90.90% |
| 2019 | 5.93 | -16.23% |
| 2018 | 7.08 | -25.11% |
| 2017 | 9.45 | -19.91% |
| 2016 | 11.80 | -26.76% |
| 2015 | 16.11 | -39.63% |
| 2014 | 26.68 | -37.95% |
| 2013 | 43.00 | -34.49% |
| 2012 | 65.64 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 3.4297 | -26.78% |
US
|
|
| 2.4161 | -48.42% |
IE
|
|
| 4.9278 | 5.21% |
US
|
|
| 2.6381 | -43.68% |
US
|
|
| 2.4467 | -47.76% |
DE
|
